NCT00460096View on ClinicalTrials.gov

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

September 30, 2007

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG

Kamada-API

Trial Locations (3)

32610

University of Florida School of Medicine, Gainesville

80206

National Jewish Medical and Research Center, Denver

75708-3154

The University of Texas Health Center at Tyler, Tyler

All Listed Sponsors

lead

Kamada, Ltd.

INDUSTRY

NCT00460096 - Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency | Biotech Hunter | Biotech Hunter